[Proceedings: The clinical effects of human growth hormone. Report on an international symposium of the German Kabi Corp. on February 15, 1975 in Munich].
Report of an International Symposion (Febr. 15, 1975, Munich). Human growth hormone (HGH) acts on proliferation of cartilage, the basal process of growth, by the way of somatomedine and changes in protein metabolism. Growth can be enhanced in hypopituitary dwardism and with higher dosage in other forms of failure to thrive. HGH also seems to have a beneficial effect in patients with muscular dystrophy as shown in a preliminary report but not in thrombocytopenia. First observations on patients with osteogenesis imperfecta and on patients with non healing fractures of the long bones (pseudarthroses) have shown significant improvement. Of importance are the reports on stopping severe gastric hemorrhage in patients with stress ulcera.
D001846:Bone Development; D004392:Dwarfism / Q000628:therapy; D005260:Female; D050723:Fractures, Bone / Q000628:therapy; D013006:Growth Hormone / Q000378:metabolism / Q000627:therapeutic use*; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D008297:Male; D009136:Muscular Dystrophies / Q000628:therapy; D010013:Osteogenesis Imperfecta / Q000628:therapy; D010024:Osteoporosis / Q000628:therapy; D010026:Osteosclerosis / Q000628:therapy; D013002:Somatomedins / Q000378:metabolism / Q000494:pharmacology; D013312:Stress, Physiological / Q000628:therapy; D014424:Turner Syndrome / Q000628:therapy
D013002:Somatomedins; D013006:Growth Hormone
Die klinischen Wirkungen von humanem Wachstumshormon. Bericht über ein internationales Symposium der Deutschen Kabi GmbH am 15. Februar 1975 in München